AI assistant
RESMED INC — Director's Dealing 2012
Nov 5, 2012
30071_dirs_2012-11-05_47fac808-ff0b-474d-adb7-e46e9dc750ea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-11-01
Reporting Person: Farrell Michael J. (President - Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-01 | ResMed Common Stock | M | 20000 | $21.71 | Acquired | 119299.806 | Direct |
| 2012-11-01 | ResMed Common Stock | S | 20000 | $40.797 | Disposed | 99299.806 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-01 | ResMed Common Stock Options | $21.710 | M | 20000 | Disposed | 2014-08-01 | ResMed Common Stock (20000) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 each year on the anniversary of the grant.
F2: Includes 175.004 shares purchased on October 31, 2012, through the company Employee Stock Purchase Plan.
F3: This transaction was executed in multiple trades at prices ranging from $40.74-$40.82. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transactin was effected upon request to the SEC staff, the issuer or the security holder of the issuer.